BGI's gene sequencer spinoff, MGI Tech, has secured $200m in funding from Goldstone Investment, Green Pine Capital and Orient Securities despite a reported $1bn target.
Therachon, which had raised $100m from investors including Pfizer Ventures and Novo, has agreed to be acquired by Pfizer in a deal that could potentially reach $810m.
Corporate joint venture Echo Health Ventures led a $33m funding round that will help fund the home care access platform's expansion in the US.
Bloomberg has backed Unshackled Ventures, which facilitates the launch of companies by migrants and immigrants in the US, helping it reach a $20m close for its second fund.
The financial comparison platform has received a total of $80m to date from investors including Aegon, at least $30m of which was secured in 2019.
Promethera Biosciences has increased its series D round to $44.4m with a $33.1m Mitsui and Medipal-backed extension, adding to Itochu’s initial investment earlier this year.
Existing backer Samsung Ventures contributed to a round that boosted the health maintenance platform developer's overall funding to more than $86m.
Ola's electric vehicle-focused spinoff has added an undisclosed amount to the $56m in series A funding the company received in March.
Center Laboratories Group and Formosa Laboratories are in line for exits as cancer drug developer Tot Biopharm aims to go public.
The app-based electric bicycle rental service will use the proceeds from the round, which was led by Denso New Mobility Group, to expand in the US.